These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33383842)
1. Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives. Chen T; Huang Y; Hong J; Wei X; Zeng F; Li J; Ye G; Yuan J; Long Y Mar Drugs; 2020 Dec; 19(1):. PubMed ID: 33383842 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor. Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727 [TBL] [Abstract][Full Text] [Related]
3. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies. El-Sayed NA; Nour MS; Salem MA; Arafa RK Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778 [TBL] [Abstract][Full Text] [Related]
4. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. Sever B; Altıntop MD; Kuş G; Özkurt M; Özdemir A; Kaplancıklı ZA Eur J Med Chem; 2016 May; 113():179-86. PubMed ID: 26927686 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020 [TBL] [Abstract][Full Text] [Related]
6. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779 [TBL] [Abstract][Full Text] [Related]
7. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities. Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition. El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576 [TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861 [TBL] [Abstract][Full Text] [Related]
11. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects. Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. Lamie PF; Philoppes JN; Rárová L Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity. Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Şenkardeş S; Han Mİ; Kulabaş N; Abbak M; Çevik Ö; Küçükgüzel İ; Küçükgüzel ŞG Mol Divers; 2020 Aug; 24(3):673-689. PubMed ID: 31302853 [TBL] [Abstract][Full Text] [Related]
16. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity. Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353 [TBL] [Abstract][Full Text] [Related]